Hui Pang

1.0k total citations
37 papers, 713 citations indexed

About

Hui Pang is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Hui Pang has authored 37 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Cancer Research and 12 papers in Molecular Biology. Recurrent topics in Hui Pang's work include Breast Cancer Treatment Studies (6 papers), Cancer Treatment and Pharmacology (5 papers) and Folate and B Vitamins Research (4 papers). Hui Pang is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Cancer Treatment and Pharmacology (5 papers) and Folate and B Vitamins Research (4 papers). Hui Pang collaborates with scholars based in China and United States. Hui Pang's co-authors include Xiaoqun Dong, Li Cai, Yanbin Zhao, Qingwei Meng, Xuesong Chen, Hailing Lu, Qiang Shen, Jiguang Han, Lichun Sun and Jie Hao and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Hui Pang

33 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Pang China 15 382 279 241 85 79 37 713
Jin He China 16 570 1.5× 356 1.3× 167 0.7× 57 0.7× 98 1.2× 47 907
Fei Lian United States 16 336 0.9× 163 0.6× 192 0.8× 48 0.6× 214 2.7× 33 672
Abul Elahi United States 17 628 1.6× 361 1.3× 252 1.0× 109 1.3× 238 3.0× 31 1.0k
Francesca Maria Tumminello Italy 14 278 0.7× 176 0.6× 187 0.8× 45 0.5× 62 0.8× 17 575
Tomoyo Yasui Japan 15 263 0.7× 156 0.6× 202 0.8× 37 0.4× 72 0.9× 58 637
Jolanta Pamuła‐Piłat Poland 15 719 1.9× 381 1.4× 297 1.2× 46 0.5× 86 1.1× 30 1.0k
Patrícia Matos Biselli-Chicote Brazil 13 306 0.8× 145 0.5× 64 0.3× 77 0.9× 50 0.6× 26 533
Yuichiro Yokoyama Japan 15 348 0.9× 152 0.5× 287 1.2× 62 0.7× 95 1.2× 89 937
Yuefeng Du China 16 406 1.1× 202 0.7× 144 0.6× 76 0.9× 213 2.7× 35 761

Countries citing papers authored by Hui Pang

Since Specialization
Citations

This map shows the geographic impact of Hui Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Pang more than expected).

Fields of papers citing papers by Hui Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Pang. The network helps show where Hui Pang may publish in the future.

Co-authorship network of co-authors of Hui Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Pang. A scholar is included among the top collaborators of Hui Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Pang. Hui Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tian, Bin, Xi Shen, Hui Pang, et al.. (2025). Location-Specific Net Water Uptake and Malignant Cerebral Edema in Acute Anterior Circulation Occlusion Ischemic Stroke. American Journal of Neuroradiology. 46(7). 1329–1335.
3.
4.
Xu, Jing, Xu Zhu, Yujie Xing, et al.. (2024). Associations of dietary flavonoid intake with the risk of all-cause and cardiovascular mortality in adults. Clinical Nutrition ESPEN. 62. 270–277. 1 indexed citations
5.
Zhu, Xu, et al.. (2024). Associations of urinary volatile organic compounds with cardiovascular disease among the general adult population. International Journal of Environmental Health Research. 34(11). 3876–3890. 3 indexed citations
6.
Shi, Yan, Hui Pang, Lichun Sun, et al.. (2023). Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial. BMC Cancer. 23(1). 463–463. 6 indexed citations
7.
8.
9.
Huang, Jian, Yunfeng Han, Jie Hao, et al.. (2018). The microRNA miR-181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin. International Journal of Biological Macromolecules. 125. 544–556. 40 indexed citations
10.
11.
Pang, Hui, et al.. (2018). Association between homocysteine and conventional predisposing factors on risk of stroke in patients with hypertension. Scientific Reports. 8(1). 3900–3900. 17 indexed citations
12.
13.
Pang, Hui, Ting Feng, Hailing Lu, et al.. (2016). Efficacy and Safety of Nedaplatin in Advanced Breast Cancer Therapy. Cancer Investigation. 34(4). 167–172. 4 indexed citations
14.
Hu, Jing, Dongdong Yang, Huijuan Zhang, et al.. (2015). USP22 promotes tumor progression and induces epithelial–mesenchymal transition in lung adenocarcinoma. Lung Cancer. 88(3). 239–245. 41 indexed citations
15.
Pang, Hui. (2015). GW26-e2258 Stroke incidence in individuals with an elevated plasma homocysteine concentration. Journal of the American College of Cardiology. 66(16). C237–C237. 1 indexed citations
16.
Chen, Xuesong, Lichun Sun, Yingying Cong, et al.. (2014). Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer. Journal of Experimental & Clinical Cancer Research. 33(1). 28–28. 19 indexed citations
17.
Chen, Xuesong, Yingying Cong, Ying Jiang, et al.. (2014). Luminal (Her2 negative) prognostic index and survival of breast cancer patients. Cancer Epidemiology. 38(3). 286–290. 11 indexed citations
18.
Zhao, Yanbin, Hailing Lu, Yan An, et al.. (2013). ABCC3 as a marker for multidrug resistance in non-small cell lung cancer. Scientific Reports. 3(1). 3120–3120. 64 indexed citations
19.
Pang, Hui, et al.. (2011). Knockdown of Osteopontin Chemosensitizes MDA-MB-231 Cells to Cyclophosphamide by Enhancing Apoptosis Through Activating p38 MAPK Pathway. Cancer Biotherapy and Radiopharmaceuticals. 26(2). 165–173. 52 indexed citations
20.
Nguyen, Thang Van, Nahum Puebla‐Osorio, Hui Pang, Melanie Dujka, & Chengming Zhu. (2007). DNA damage-induced cellular senescence is sufficient to suppress tumorigenesis: a mouse model. The Journal of Experimental Medicine. 204(6). 1453–1461. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin He Breakdown of academic impact, for papers by Fei Lian Breakdown of academic impact, for papers by Abul Elahi Breakdown of academic impact, for papers by Francesca Maria Tumminello Breakdown of academic impact, for papers by Tomoyo Yasui Breakdown of academic impact, for papers by Jolanta Pamuła‐Piłat Breakdown of academic impact, for papers by Patrícia Matos Biselli-Chicote Breakdown of academic impact, for papers by Yuichiro Yokoyama Breakdown of academic impact, for papers by Yuefeng Du
Rankless by CCL
2026